VCCV: conservative transcriptomic corroboration for measurement prioritization of computational drug-target hypotheses.

IF 5.4
Haihui Huang, Yanan Zhou, Dingkui Kang, Yong Liang
{"title":"VCCV: conservative transcriptomic corroboration for measurement prioritization of computational drug-target hypotheses.","authors":"Haihui Huang, Yanan Zhou, Dingkui Kang, Yong Liang","doi":"10.1093/bioinformatics/btag694","DOIUrl":null,"url":null,"abstract":"<p><strong>Motivation: </strong>Computational drug-target interaction (DTI) models nominate plausible binders but cannot determine which candidate best accounts for an observed cellular response. Perturbational transcriptomics offers orthogonal mechanistic evidence, yet pharmacology-to-genetics mismatch, incomplete reference coverage, and non-specific stress programs make simple signature matching unreliable. This motivates a principled integration layer that corroborates hypotheses conservatively, abstains under global mismatch, and prioritizes informative follow-up measurements when the evidence remains ambiguous.</p><p><strong>Results: </strong>We present Virtual-to-Cellular Corroboration for Validation (VCCV), a model-agnostic posterior-triage layer for pre-trained DTI models. VCCV updates calibrated DTI working weights with context-aligned perturbational evidence using a near-identity affine map and exact covariance transport. Within the stated Gaussian class, exact transport is the unique uncertainty update that preserves posterior-odds comparisons under invertible affine changes of measurement coordinates. VCCV also introduces an empirical warning branch for abstention and converts residual ambiguity into compact follow-up gene panels, using a submodular objective for deep near-ties. Each query is assigned one of three actionable states: a target-resolved hypothesis, an abstention, or a prioritized panel. Across five DTI models, VCCV improved discrimination (paired ROC-AUC gains 0.021-0.037) and reduced negative log-likelihood in every case. Additional evaluations showed improved ranking on the same-cell-supported endpoint, warning-score discrimination of strong-response profiles (ROC-AUC 0.876), and better recovery of full-coordinate leading hypotheses by selected panels than by random panels. Across these retrospective kinase-focused evaluations, VCCV provides a principled bridge from computational nomination to conservative, measurement-directed cellular corroboration.</p><p><strong>Availability and implementation: </strong>Source code of VCCV is publicly available at https://github.com/bio-ai-source/VCCV.</p>","PeriodicalId":93899,"journal":{"name":"Bioinformatics (Oxford, England)","volume":" ","pages":""},"PeriodicalIF":5.4000,"publicationDate":"2026-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13633670/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bioinformatics (Oxford, England)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/bioinformatics/btag694","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Motivation: Computational drug-target interaction (DTI) models nominate plausible binders but cannot determine which candidate best accounts for an observed cellular response. Perturbational transcriptomics offers orthogonal mechanistic evidence, yet pharmacology-to-genetics mismatch, incomplete reference coverage, and non-specific stress programs make simple signature matching unreliable. This motivates a principled integration layer that corroborates hypotheses conservatively, abstains under global mismatch, and prioritizes informative follow-up measurements when the evidence remains ambiguous.

Results: We present Virtual-to-Cellular Corroboration for Validation (VCCV), a model-agnostic posterior-triage layer for pre-trained DTI models. VCCV updates calibrated DTI working weights with context-aligned perturbational evidence using a near-identity affine map and exact covariance transport. Within the stated Gaussian class, exact transport is the unique uncertainty update that preserves posterior-odds comparisons under invertible affine changes of measurement coordinates. VCCV also introduces an empirical warning branch for abstention and converts residual ambiguity into compact follow-up gene panels, using a submodular objective for deep near-ties. Each query is assigned one of three actionable states: a target-resolved hypothesis, an abstention, or a prioritized panel. Across five DTI models, VCCV improved discrimination (paired ROC-AUC gains 0.021-0.037) and reduced negative log-likelihood in every case. Additional evaluations showed improved ranking on the same-cell-supported endpoint, warning-score discrimination of strong-response profiles (ROC-AUC 0.876), and better recovery of full-coordinate leading hypotheses by selected panels than by random panels. Across these retrospective kinase-focused evaluations, VCCV provides a principled bridge from computational nomination to conservative, measurement-directed cellular corroboration.

Availability and implementation: Source code of VCCV is publicly available at https://github.com/bio-ai-source/VCCV.

VCCV:计算药物靶点假设的测量优先级的保守转录组确证。
动机:计算药物-靶标相互作用(DTI)模型提名合理的结合物,但不能确定哪种候选物最能解释观察到的细胞反应。微扰转录组学提供了正交的机制证据,然而,药理学与遗传学的不匹配、不完整的参考覆盖和非特异性应激程序使得简单的特征匹配不可靠。这激发了一个有原则的整合层,保守地证实假设,在全局不匹配下弃权,当证据仍然不明确时优先考虑信息的后续测量。结果:我们提出了虚拟到细胞的验证确证(VCCV),这是一个模型不可知的后检层,用于预训练的DTI模型。VCCV更新校准DTI工作权与上下文对齐的扰动证据使用近恒等仿射映射和精确协方差传输。在所述的高斯类中,精确传输是唯一的不确定性更新,它在测量坐标的可逆仿射变化下保留后验几率比较。VCCV还引入了一个经验警告分支用于弃权,并将剩余模糊转换为紧凑的后续基因面板,使用子模块目标进行深度近联系。为每个查询分配三种可操作状态之一:目标解析的假设、弃权或优先级面板。在五个DTI模型中,VCCV提高了识别能力(配对ROC-AUC增益0.021-0.037),并降低了每种情况下的负对数似然。额外的评估显示,在相同细胞支持的终点上排名更高,强反应谱的警告评分区分(ROC-AUC 0.876),选择小组比随机小组更好地恢复了全坐标领先假设。在这些以激酶为中心的回顾性评估中,VCCV提供了从计算提名到保守的、以测量为导向的细胞确证的原则性桥梁。可用性和实现:VCCV的源代码可在https://github.com/bio-ai-source/VCCV.Supplementary上公开获取:补充数据可在线获取。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书